Structural basis for the substrate specificity of tobacco etch virus protease

被引:198
作者
Phan, J [1 ]
Zdanov, A [1 ]
Evdokimov, AG [1 ]
Tropea, JE [1 ]
Peters, HK [1 ]
Kapust, RB [1 ]
Li, M [1 ]
Wlodawer, A [1 ]
Waugh, DS [1 ]
机构
[1] NCI, Macromol Crystallog Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA
关键词
D O I
10.1074/jbc.M207224200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Because of its stringent sequence specificity, the 3C-type protease from tobacco etch virus (TEV) is frequently used to remove affinity tags from recombinant proteins. It is unclear, however, exactly how TEV protease recognizes its substrates with such high selectivity. The crystal structures of two TEV protease mutants, inactive C151A and autolysis-resistant S219D, have now been solved at 2.2- and 1.8-Angstrom resolution as complexes with a substrate and product peptide, respectively. The enzyme does not appear to have been perturbed by the mutations in either structure, and the modes of binding of the product and substrate are virtually identical. Analysis of the protein-ligand interactions helps to delineate the structural determinants of substrate specificity and provides guidance for reengineering the enzyme to further improve its utility for biotechnological applications.
引用
收藏
页码:50564 / 50572
页数:9
相关论文
共 39 条
[1]   PICORNAVIRAL 3C CYSTEINE PROTEINASES HAVE A FOLD SIMILAR TO CHYMOTRYPSIN-LIKE SERINE PROTEINASES [J].
ALLAIRE, M ;
CHERNAIA, MM ;
MALCOLM, BA ;
JAMES, MNG .
NATURE, 1994, 369 (6475) :72-76
[2]   The refined crystal structure of the 3C gene product from hepatitis A virus: Specific proteinase activity and RNA recognition [J].
Bergmann, EM ;
Mosimann, SC ;
Chernaia, MM ;
Malcolm, BA ;
James, MNG .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2436-2448
[3]   Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis a virus (HAV) and implications for the polyprotein processing in HAV [J].
Bergmann, EM ;
Cherney, MM ;
Mckendrick, J ;
Frormann, S ;
Luo, C ;
Malcolm, BA ;
Vederas, JC ;
James, MNG .
VIROLOGY, 1999, 265 (01) :153-163
[4]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[5]   The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 angstrom resolution [J].
Cavarelli, J ;
Prevost, G ;
Bourguet, W ;
Moulinier, L ;
Chevrier, B ;
Delagoutte, B ;
Bilwes, A ;
Mourey, L ;
Rifai, S ;
Piemont, Y ;
Moras, D .
STRUCTURE, 1997, 5 (06) :813-824
[6]  
CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062
[7]   Preparation of selenomethionyl proteins for phase determination [J].
Doublie, S .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :523-530
[8]   MOLECULAR GENETIC-ANALYSIS OF A PLANT-VIRUS POLYPROTEIN CLEAVAGE SITE - A MODEL [J].
DOUGHERTY, WG ;
CARY, SM ;
PARKS, TD .
VIROLOGY, 1989, 171 (02) :356-364
[9]   Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies [J].
Dragovich, PS ;
Webber, SE ;
Babine, RE ;
Fuhrman, SA ;
Patick, AK ;
Matthews, DA ;
Reich, SH ;
Marakovits, JT ;
Prins, TJ ;
Zhou, R ;
Tikhe, J ;
Littlefield, ES ;
Bleckman, TM ;
Wallace, MB ;
Little, TL ;
Ford, CE ;
Meador, JW ;
Ferre, RA ;
Brown, EL ;
Binford, SL ;
DeLisle, DM ;
Worland, ST .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) :2819-2834
[10]   SOLVENT STRUCTURE IN CRYSTALS OF TRYPSIN DETERMINED BY X-RAY AND NEUTRON-DIFFRACTION [J].
FINERMOORE, JS ;
KOSSIAKOFF, AA ;
HURLEY, JH ;
EARNEST, T ;
STROUD, RM .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1992, 12 (03) :203-222